Skip to main content

Table 2 Multivariate Cox regression for PFS and OS

From: Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab

Multivariate Cox regression

Hazard ratio

Std error

95% CI

P-value

PFS

    

Age

0.98

0.02

0.94, 1.02

0.281

Pre-treatment enhancing volume (cc)

1.01

0.01

0.98, 1.03

0.665

Pre-treatment atlas-defined hypervasc. vol. (cc)

3.64

0.58

1.16, 11.41

0.027*

OS

    

Age

1.04

0.03

0.98,1.10

0.195

Post-treatment enhancing volume (cc)

1.05

0.03

1.0,111

0.060

Post-treatment atlas-defined hypervasc. vol. (cc)

6.15

0.73

1.46,25.87

0.013*

  1. *= P < 0.05.